Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
Annals of the Rheumatic Diseases
2019
78
9
1242-1248
The methylisothiazolinone epidemic goes along with changing patients' characteristics – After cosmetics, industrial applications are the focus
Contact Dermatitis
2019
82
2
87-93
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort
Annals of the Rheumatic Diseases
2019
78
5
648-656
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
Arthritis & Rheumatology
2019
71
9
1553-1570
Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells.
Cells
2019
8
10
Role and Mechanism of Galactose-Alpha-1,3-Galactose in the Elicitation of Delayed Anaphylactic Reactions to Red Meat.
Curr Allergy Asthma Rep
2019
19
1
Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.
Acta Derm Venereol
2019
99
6
508-515
Galactose α-1,3-galactose phenotypes: Lessons from various patient populations.
Ann Allergy Asthma Immunol
2019
122
6
598-602
50 Years of the Department of Dermatology and Allergy Biederstein in Munich
Aktuelle Derm
2019
45
6
261-272